Chengdu Kanghua Biological Products Future Growth
Future criteria checks 2/6
Chengdu Kanghua Biological Products is forecast to grow earnings and revenue by 16% and 14% per annum respectively. EPS is expected to grow by 15.7% per annum. Return on equity is forecast to be 16.7% in 3 years.
Key information
16.0%
Earnings growth rate
15.7%
EPS growth rate
| Biotechs earnings growth | 39.6% |
| Revenue growth rate | 14.0% |
| Future return on equity | 16.7% |
| Analyst coverage | Low |
| Last updated | 22 Aug 2024 |
Recent future growth updates
Recent updates
The Market Doesn't Like What It Sees From Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Earnings Yet
Sep 13
We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt
Jun 26Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares
Feb 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,414 | 885 | N/A | 923 | 4 |
| 12/31/2025 | 2,156 | 790 | N/A | 573 | 4 |
| 12/31/2024 | 1,893 | 704 | N/A | 752 | 4 |
| 6/30/2024 | 1,684 | 568 | 491 | 628 | N/A |
| 3/31/2024 | 1,611 | 553 | 523 | 656 | N/A |
| 12/31/2023 | 1,577 | 509 | 417 | 574 | N/A |
| 9/30/2023 | 1,382 | 484 | 233 | 440 | N/A |
| 6/30/2023 | 1,421 | 531 | 72 | 384 | N/A |
| 3/31/2023 | 1,458 | 568 | -85 | 324 | N/A |
| 1/1/2023 | 1,447 | 598 | -224 | 195 | N/A |
| 9/30/2022 | 1,567 | 729 | -246 | 138 | N/A |
| 6/30/2022 | 1,400 | 893 | -310 | 83 | N/A |
| 3/31/2022 | 1,322 | 864 | -274 | 82 | N/A |
| 1/1/2022 | 1,292 | 829 | -185 | 130 | N/A |
| 9/30/2021 | 993 | 648 | -203 | 97 | N/A |
| 6/30/2021 | 1,136 | 478 | 35 | 213 | N/A |
| 3/31/2021 | 1,119 | 444 | 158 | 302 | N/A |
| 12/31/2020 | 1,039 | 408 | 234 | 370 | N/A |
| 9/30/2020 | 1,085 | 442 | 237 | 327 | N/A |
| 6/30/2020 | 739 | 285 | 188 | 263 | N/A |
| 3/31/2020 | 581 | 216 | 123 | 166 | N/A |
| 12/31/2019 | 555 | 187 | 159 | 183 | N/A |
| 9/30/2019 | 425 | 101 | 170 | 189 | N/A |
| 12/31/2018 | 559 | 154 | 23 | 57 | N/A |
| 12/31/2017 | 262 | 74 | N/A | 90 | N/A |
| 12/31/2016 | 93 | 7 | N/A | 3 | N/A |
| 12/31/2015 | 71 | 12 | N/A | 7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300841's forecast earnings growth (16% per year) is above the savings rate (2.9%).
Earnings vs Market: 300841's earnings (16% per year) are forecast to grow slower than the CN market (23.2% per year).
High Growth Earnings: 300841's earnings are forecast to grow, but not significantly.
Revenue vs Market: 300841's revenue (14% per year) is forecast to grow faster than the CN market (13.3% per year).
High Growth Revenue: 300841's revenue (14% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300841's Return on Equity is forecast to be low in 3 years time (16.7%).